Compatibility of selected critical care drugs during simulated Y-site administration

American Journal of Health-System Pharmacy

Volumn 53, Issue 9, 1996, Pages 1048-1051

  Yamashita, Sharon K ^a,b   Walker, Scott E ^c,d   Choudhury, Taffik ^c,e   Iazzetta, John ^c,d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SHSC   (Canada)

^d Faculty of Pharmacy   (United States)

^e York Central Hospital Richmond Hill   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DOBUTAMINE; DOPAMINE; ESMOLOL; GLYCERYL TRINITRATE; HEPARIN; ISOPHANE INSULIN; LABETALOL; MIDAZOLAM; MORPHINE SULFATE; NITROPRUSSIDE SODIUM; NORADRENALIN BITARTRATE;

ARTICLE; DRUG INCOMPATIBILITY; DRUG MIXTURE; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; VASCULAR ACCESS;

EID: 0029892093     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.9.1048     Document Type: Article

References (5)

1. Trissel LA. Avoiding common flaws in stability and compatibility studies of injectable drugs. Am J Hosp Pharm. 1983; 40: 1159-60. Editorial.
2. Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-49.
3. Trissel LA. Handbook on injectable drugs. 6th ed, Bethesda, MD: American Society of Hospital Pharmacists; 1990.
4. Kershaw BP, Monnier HL, Mason JH. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration. Am J Hosp Pharm. 1993; 50:1360,1362-3. Letter.
5. Trissel LA. Were the bubbles evolved or entrained? Am J Health-System Pharm. 1995; 52:757. Letter.